ArticleHealth affairs scholar2023

Food and Drug Administration novel drug decisions in 2017: transparency and disclosure prior to and 5 years following approval.

Robert M Kaplan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.